Search all trials

Find therapies in clinical trials near you – page 28

Search by disease and location to discover available clinical trials matching your criteria. Updated every day from authoritative EU registries.

recruiting: 3 961
countries: 28
conditions: 2 103

3 961 trials recruiting28 European countries2 103 conditions coveredUpdated today

Quick filters

Acute myocardial infarction

Not recruiting

Registered drugNo placebo

Study on Ticagrelor for Patients with Heart Attack After Coronary Stenting

Registered drugNo placebo

Sweden

Participants:18–64 years · 65+ years
Substances:Ticagrelor

Contact Research Centre

Cystic fibrosis

Not recruiting

Registered drugNo placebo

Study on Long-term Safety of VX-121, Tezacaftor, and Deutivacaftor in Patients with Cystic Fibrosis

Registered drugNo placebo

Sweden

Participants:0–17 years · 18–64 years · 65+ years
Substances:Deutivacaftor

Contact Research Centre

Colitis ulcerative

Not recruiting

Registered drugNo placebo

Study of Tofacitinib for Children with Moderate to Severe Ulcerative Colitis

Registered drugNo placebo

Sweden

Participants:0–17 years
Substances:Tofacitinib

Contact Research Centre

Short-bowel syndrome

Not recruiting

InvestigationalNo placebo

Long-term safety study of apraglutide (weekly injections) in patients with Short Bowel Syndrome

InvestigationalNo placebo

Sweden

Participants:18–64 years · 65+ years
Substances:Apraglutide

Contact Research Centre

Multiple sclerosis

Not recruiting

Registered drugNo placebo

Study on Long-Term Safety and Efficacy of Ocrelizumab for Patients with Multiple Sclerosis

Registered drugNo placebo

Sweden

Participants:18–64 years
Substances:Ocrelizumab

Contact Research Centre

Malignant melanoma stage III

Not recruiting

Registered drug

Study on Pembrolizumab for Patients with High-Risk Stage III Melanoma After Surgery

Registered drug

Sweden

Participants:18–64 years · 65+ years
Substances:Pembrolizumab

Contact Research Centre

C3 glomerulopathy

Not recruiting

Registered drugNo placebo

Study Comparing Aliskiren and Enalapril for Patients with C3 Glomerulopathy

Registered drugNo placebo

Sweden

Participants:0–17 years · 18–64 years · 65+ years
Substances:Aliskiren

Contact Research Centre

Plasma cell myeloma refractory

Not recruiting

Registered drugNo placebo

Study Comparing Teclistamab with Daratumumab, Pomalidomide, and Dexamethasone for Patients with Relapsed or Refractory Multiple Myeloma

Registered drugNo placebo

Sweden

Participants:18–64 years · 65+ years
Substances:Bortezomib

Contact Research Centre

Dementia Alzheimer's type+1

Not recruiting

InvestigationalNo placebo

Study of Lecanemab (BAN2401) Treatment in People with Early Alzheimer's Disease: Testing Safety and Effectiveness Over 18 Months

InvestigationalNo placebo

Sweden

Participants:18–64 years · 65+ years
Substances:Lecanemab

Contact Research Centre

Chronic lymphocytic leukaemia

Not recruiting

Registered drugNo placebo

Study Comparing Ibrutinib, Venetoclax, and Obinutuzumab for Untreated Chronic Lymphocytic Leukemia Patients

Registered drugNo placebo

Sweden

Participants:18–64 years · 65+ years
Substances:Ibrutinib

Contact Research Centre

Atrial fibrillation+2

Not recruiting

Registered drug

Study on Asundexian and Apixaban for Preventing Stroke in Adults with Atrial Fibrillation at Risk for Stroke

Registered drug

Sweden

Participants:18–64 years · 65+ years
Substances:Apixaban

Contact Research Centre

Malignant melanoma

Not recruiting

Registered drug

Study of mRNA-4157 and Pembrolizumab for Patients with High-Risk Stage II-IV Melanoma

Registered drug

Sweden

Participants:18–64 years · 65+ years
Substances:Mrna-4157

Contact Research Centre

Find therapies in clinical trials near you – page 28

376 trials match your criteria

Acute myocardial infarction

Study on Ticagrelor for Patients with Heart Attack After Coronary Stenting

Cystic fibrosis

Study on Long-term Safety of VX-121, Tezacaftor, and Deutivacaftor in Patients with Cystic Fibrosis

Colitis ulcerative

Study of Tofacitinib for Children with Moderate to Severe Ulcerative Colitis

Short-bowel syndrome

Long-term safety study of apraglutide (weekly injections) in patients with Short Bowel Syndrome

Multiple sclerosis

Study on Long-Term Safety and Efficacy of Ocrelizumab for Patients with Multiple Sclerosis

Malignant melanoma stage III

Study on Pembrolizumab for Patients with High-Risk Stage III Melanoma After Surgery

C3 glomerulopathy

Study Comparing Aliskiren and Enalapril for Patients with C3 Glomerulopathy

Plasma cell myeloma refractory

Study Comparing Teclistamab with Daratumumab, Pomalidomide, and Dexamethasone for Patients with Relapsed or Refractory Multiple Myeloma

Dementia Alzheimer's type+1

Study of Lecanemab (BAN2401) Treatment in People with Early Alzheimer's Disease: Testing Safety and Effectiveness Over 18 Months

Chronic lymphocytic leukaemia

Study Comparing Ibrutinib, Venetoclax, and Obinutuzumab for Untreated Chronic Lymphocytic Leukemia Patients

Atrial fibrillation+2

Study on Asundexian and Apixaban for Preventing Stroke in Adults with Atrial Fibrillation at Risk for Stroke

Malignant melanoma

Study of mRNA-4157 and Pembrolizumab for Patients with High-Risk Stage II-IV Melanoma

Explore other searches

Vaccine trials

Paediatric trials · ages 0–17

Healthy volunteers

Helpful resources

How applying through us works

What happens after you apply

Guides for patients and volunteers

Search filters

Prefer not to search? Our Concierge searches the trials for you.